Fidelity Investments’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $974M | Sell |
|
|||||
|
2025
Q1 | $1.27B | Buy |
|
|||||
|
2024
Q4 | $1.81B | Buy |
|
|||||
|
2024
Q3 | $1.13B | Buy |
|
|||||
|
2024
Q2 | $682M | Buy |
|
|||||
|
2024
Q1 | $300M | Buy |
|
|||||
|
2023
Q4 | $28.5M | Buy |
|
|||||
|
2023
Q3 | $26.2M | Buy |
|
|||||
|
2023
Q2 | $528K | Sell |
|
|||||
|
2023
Q1 | $1.28M | Buy |
|
|||||
|
2022
Q4 | $1.31M | Buy |
|
|||||
|
2022
Q3 | $724K | Sell |
|
|||||
|
2022
Q2 | $815K | Buy |
|
|||||
|
2022
Q1 | $555K | Sell |
|
|||||
|
2021
Q4 | $978K | Buy |
|
|||||
|
2021
Q3 | $513K | Buy |
|
|||||
|
2021
Q2 | $450K | Sell |
|
|||||
|
2021
Q1 | $566K | Buy |
|
|||||
|
2020
Q4 | $425K | Buy |
|
|||||
|
2020
Q3 | $277K | Sell |
|
|||||
|
2020
Q2 | $101M | Buy |
|
|||||
|
2020
Q1 | $10.4M | Buy |
|
|||||
|
2019
Q4 | $6.8M | Sell |
|
|||||
|
2019
Q3 | $6.22M | Sell |
|
|||||
|
2019
Q2 | $56.3M | Sell |
|
|||||
|
2019
Q1 | $268M | Sell |
|
|||||
|
2018
Q4 | $544M | Buy |
|
|||||
|
2018
Q3 | $527M | Buy |
|
|||||
|
2018
Q2 | $500M | Sell |
|
|||||
|
2018
Q1 | $385M | Sell |
|
|||||
|
2017
Q4 | $467M | Sell |
|
|||||
|
2017
Q3 | $459M | Sell |
|
|||||
|
2017
Q2 | $1.42B | Buy |
|
|||||
|
2017
Q1 | $1.18B | Sell |
|
|||||
|
2016
Q4 | $2.28B | Sell |
|
|||||
|
2016
Q3 | $3.11B | Sell |
|
|||||
|
2016
Q2 | $3.43B | Sell |
|
|||||
|
2016
Q1 | $4.17B | Sell |
|
|||||
|
2015
Q4 | $5.6B | Buy |
|
|||||
|
2015
Q3 | $4.11B | Buy |
|
|||||
|
2015
Q2 | $3.84B | Buy |
|
|||||
|
2015
Q1 | $3.49B | Buy |
|
|||||
|
2014
Q4 | $2.71B | Buy |
|
|||||
|
2014
Q3 | $2.15B | Buy |
|
|||||
|
2014
Q2 | $2.08B | Buy |
|
|||||
|
2014
Q1 | $1.43B | Buy |
|
|||||
|
2013
Q4 | $377M | Buy |
|
|||||
|
2013
Q3 | $328M | Buy |
|
|||||
|
2013
Q2 | $129M | Buy |
|